ABSTRACT
Ganoderma, commonly recognized as reishi, is a medicinal mushroom widely utilized in traditional medicine for various health advantages. Recently, numerous investigations have explored the potential hypolipidemic and cholesterol-reducing properties of Ganoderma. This literature review seeks to condense the current scientific proof concerning the impacts of Ganoderma on lipid metabolism and levels of cholesterol. The review delves into the fundamental mechanisms of action, such as hindering cholesterol production, stimulating cholesterol elimination, and regulating genes linked to lipid metabolism. Additionally, the review offers insights into the possible therapeutic applications of Ganoderma in the treatment of dyslipidemia and cardiovascular ailments. All in all, the existing literature suggests that Ganoderma might exhibit favorable impacts on lipid profiles and could serve as a promising dietary supplement for individuals with hyperlipidemia. However, further extensive research, including randomized controlled trials, is imperative to substantiate these findings and establish the optimal dosages and safety profiles of Ganoderma for clinical usage.
